title: A step towards treating KRAS-mutant NSCLC.
authors.affiliation: Yale Comprehensive Cancer Center, Yale University School of Medicine, New Haven, CT 06520, USA.
authors.forename: Sarah B
authors.initials: SB
authors.lastname: Goldberg
authors.forename: Joseph
authors.initials: J
authors.lastname: Schlessinger
authors.forename: Julie L
authors.initials: JL
authors.lastname: Boyer
authors.forename: Roy S
authors.initials: RS
authors.lastname: Herbst
mesh_terms: D001562:Benzimidazoles / Q000008:administration & dosage*; D002289:Carcinoma, Non-Small-Cell Lung; D000077143:Docetaxel; D005260:Female; D006801:Humans; D008175:Lung Neoplasms; D008297:Male; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D016283:Proto-Oncogene Proteins p21(ras); D043823:Taxoids / Q000008:administration & dosage*; D018631:ras Proteins / Q000235:genetics*
chemical_list: C517975:AZD 6244; D001562:Benzimidazoles; C117307:KRAS protein, human; D011518:Proto-Oncogene Proteins; D043823:Taxoids; D000077143:Docetaxel; D016283:Proto-Oncogene Proteins p21(ras); D018631:ras Proteins